Independent:: Melanie Claire Torillo Bsn2 Leininger
Independent:: Melanie Claire Torillo Bsn2 Leininger
Independent:: Melanie Claire Torillo Bsn2 Leininger
Observe chest
size, shape, and
symmetry.
Perform health
teachings (e.g.
optimal positions
for effective
breathing)
Dependent:
Administer
respiratory
medications and
therapies as
ordered.
Nursing Diagnosis Rationale Intervention Rationale Evaluation
Impaired gas Shortness of Independent: Goal unmet.
exchange related to CLAIRE
MELANIE breath TORILLO
serves asBSN2
a 1. Assess for
LEININGER 1. To detect
shortness of breath cardinal symptom, respiratory changes in After 4 hours of
as evidenced by indicating rate, depth, respiratory providing nursing
decrease in respiratory distress and effort status care, the patient
hemoglobin and and the body's regularly. promptly. demonstrates an
hematocrit. response to improvement in
hypoxia and 2. Place the 2. To optimize breathing but the
Subjective Data: hypoxemia. patient in a lung expansion oxygen saturation is
● Parent semi-fowler’s and facilitate still below its normal
reports Schematic position. breathing. level.
difficulty Diagram:
breathing 3. Encourage 3. To help thin
and the child Shortness of adequate fluid respiratory
appears breath intake. secretions,
restless. making them
easier to clear
Decrease in
Objective Data:
oxygen saturation
● Hct: 30.4% 4. Continuously 4. To determine if
● Hgb: 9.9 monitor hematocrit and
g/dL Ineffective tissue oxygen hemoglobin is
● Shortness of perfusion saturation in normal
breath - levels using range or still
dyspnea pulse oximetry. below.
● O2 saturation Occurrence of
- 90% hypoxia and 5. Engage the 5. To promote
hypoxemia patient in deep lung expansion
Goals: breathing and improve
After 4 hours of Impaired gas exercises. gas exchange.
providing nursing exchange
care, the patient will Dependent:
demonstrate 6. Administer 6. To alleviate
improved gas bronchodilator constriction
exchange as and antibiotic and improve
evidenced by drugs as gas exchange
normal oxygen ordered. and
saturation levels respiration.
(SpO2 > 95%). Collaborative:
7. Collaborate 7. To adjust
with physicians treatment
and respiratory plans based on
therapists. the patient's
response and
MELANIE CLAIRE TORILLO BSN2 LEININGER
History of cholestatic jaundice or hepatic CNS: Aggressiveness, agitation, ● Know that azithromycin should not
dysfunction associated with prior use of anxiety, asthenia, dizziness, fatigue, be used in patients who have
azithromycin; hypersensitivity to headache, hyperactivity, malaise, undergone donor stem cell
azithromycin, erythromycin, ketolide nervousness, paresthesia, seizures, transplant for cancer of the blood
antibiotics, other macrolide antibiotics or somnolence, syncope,vertigo or lymph nodes because of an
their components increased risk for cancer relapse
CV: Arrhythmias, chest pain, edema, and possibly death.
elevated serum CK level, ●
hypotension,palpitations, prolonged QT
interval, torsades de pointes, ventricular ● Monitor elderly patients closely for
tachycardia arrhythmias because they are
more susceptible to drug effects on
EENT: Hearing loss, oral candidiasis, the QT interval.
perversion or loss of taste or ●
smell,tinnitus, tongue discoloration ● Obtain culture and sensitivity test
results, if possible, before starting
ENDO: Hyperglycemia
therapy.
GI: Abdominal pain, anorexia, ●
cholestatic jaundice, constipation, ● Use azithromycin cautiously in
diarrhea,dyspepsia, elevated liver patients with hepatic dysfunction
MELANIE CLAIRE TORILLO BSN2 LEININGER
Hypersensitivity to cetirizine, CNS: Dizziness, fatigue, feeling hot, ● Know that Quzyttir is a single-use
hydroxyzine, levocetirizine, or their headache, insomnia, injectable product for intravenous
components irritability,paresthesia, presyncope, administration only.
sedation, somnolence
EENT: Dry mouth, epistaxis,
pharyngitis, taste alteration ● Be aware that intravenous use is
not recommended in children less
GI: Abdominal pain, diarrhea, than 6 years of age with impaired
dyspepsia, nausea, vomiting hepatic or renal function.
RESP: Bronchospasm, cough
● Institute safety precautions,
SKIN: Diaphoresis because drugs can cause sedation
and somnolence.
PO MOA:
Albuterol attaches to beta2
TID receptors on bronchial cell
membranes, which
stimulates the intracellular
8AM - 1PM - 6PM
enzyme adenylate cyclase
to convert adenosine
triphosphate (ATP) to cyclic
adenosine monophosphate
(cAMP). This reaction
decreases intracellular
calcium levels. It also
increases intracellular levels
of cAMP, as shown.
Together, these effects
MELANIE CLAIRE TORILLO BSN2 LEININGER
Hypersensitivity to albuterol or its CNS: Anxiety, dizziness, drowsiness, ● Assess for the patient's vital signs
components headache, hyperkinesia, before administration to serve as a
insomnia,irritability, nervousness, baseline after administering the
tremor, vertigo, weakness ordered drug.
● Administer pressurized inhalations
CV: Angina, arrhythmias, chest pain,
hypertension, hypotension, of albuterol during second half of
palpitations inspiration, when airways are
● open wider and aerosol distribution
EENT: Altered taste, dry mouth and is more effective.
throat, ear pain, glossitis,
hoarseness,oropharyngeal edema,
pharyngitis, rhinitis, taste perversion ● Monitor serum potassium level
because albuterol may cause
ENDO: Hyperglycemia
transient hypokalemia.
GI: Anorexia, diarrhea, dysphagia,
heartburn, nausea, vomiting, ● Be aware that drug tolerance can
GU: UTI develop with prolonged use.
MS: Muscle cramps
● Monitor for abnormal changes in
RESP: Bronchospasm, cough, the patient’s vital signs in order to
dyspnea, paradoxical halt or change medication as
bronchospasm,Pulmonary edema ordered by the physician.
MELANIE CLAIRE TORILLO BSN2 LEININGER